Regenxbio: Dosing of first patient in Phase 2 AAVIATE trial for wet AMD

September 09, 2020

Interim data update from first cohort using suprachoroidal delivery of RGX-314 expected by end of 2020

Deep learning algorithm proving accurate for AMD classification

September 01, 2020

Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.

Contrast sensitivity shows potential for measuring visual function loss in early AMD

September 01, 2020

A study suggests this user-friendly platform may be useful as a supplemental visual function measure in patients with AMD.

AMD, DED most common retinal conditions in the United States

August 13, 2020

The number of patients with retinal diseases is steadily increasing in the United States, according to a retrospective study presented during ARVO 2020.

Early detection of CNV in second eye key to improving outcomes

August 10, 2020

Early detection and anti-VEGF treatment of choroidal neovascularization (CNV) in the second eye leads to better mean final visual acuity (VA) with fewer injections at 1 year.

ASRS 2020: How one surgeon is integrating recent retina advances in COVID-19

August 02, 2020

S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment